RE:RE:RE:RE:chart The company is changing its business model from the licencing to ownership of clinics. As far as my track record, well I predicted the massive decline in March. Look at my postings. Where were you ? Nowhere. Were you the one that bought at $2.50 a share in October ? While it's nice that you are a cheerleader for the stock, you should learn how to read financial statements. The company is losing money and running out of cash on hand due to operating losses and money it has spent on acquisitions. A financing will be needed this year. More dilution, more downward pressure on the stock until the company stabilizes and starts to show strong revenue growth and profits. Revenues for the last quarter were down. Check the financials on SEDAR if you know what that is. Let's hope the next reported quarter will show an increase, year over year.